1. Huang HL, Kuo CS, Chang TY, Chou RH, Chen IC, Yang FC, Chen NJ, Lin SJ, Wu CC,  Huang PH*.  An oral absorbent, AST-120, restores vascular growth and blood flow in ischemic muscles in diabetic mice via modulation of macrophage transition. J Mol Cell Cardiol. 2021;155:99-110.
2. Lu YW, Chang CC, Chou RH, Tsai YL, Liu LK, Chen LK, Huang PH* , Lin SJ. Gender difference in the association between TyG index and subclinical atherosclerosis: results from the I-Lan Longitudinal Aging Study. Cardiovasc Diabetol. 2021 ;20(1):206.
3. Liu CT, Hsu SC, Hsieh HL, Chen CH, Chen CY, Sue YM, Chen TH, Hsu YH, Lin FY, Shih CM, Shiu YT, Huang PH*. Inhibition of β-catenin signaling attenuates arteriovenous fistula thickening in mice by suppressing myofibroblasts. Mol Med. 2022 ;28(1):7.
4. Chen CY, Leu HB, Wang SC, Tsai SH, Chou RH, Lu YW, Tsai YL, Kuo CS, Huang PH* , Chen JW, Lin SJ. Inhibition of Trimethylamine N-oxide attenuates neointimal formation through reduction of inflammasome and oxidative stress in a mouse model of carotid artery ligation.  Antioxid Redox Signal. 2022. doi: 10.1089/ars.2021.0115.
5. Huang PH , Lu YW, Tsai YL, Wu YW, Li HY, Chang HY, Wu CH, Yang CY, Tarng DC, Huang CC, Ho LT, Lin CF, Chien SC, Wu YJ, Yeh HI, Pan WH, Li YH. 2022 Taiwan lipid guidelines for primary prevention. J Formos Med Assoc. 2022:S0929-6646(22)00215-7. doi: 10.1016/j.jfma.2022.05.010.

限於篇幅,以上謹為代表著作